Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01320787 | 18-F-Fluoroacetate as PET Imaging Agent | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 23, 2014 | clinicaltrials |
| NCT01688414 | Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Jul 29, 2014 | clinicaltrials |
| NCT02054793 |
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) |
| withdrawn |
| Phase 1 / Phase 2 |
| 0 |
| Emmanuel Antonarakis, MDOTHER |
| 1 |
| Jul 23, 2014 |
| clinicaltrials |
| NCT01734681 | Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | GenSpera, Inc.INDUSTRY | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01409473 | Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer(Prostate SBRT) | withdrawn | Phase 2 | 0 | Rocky Mountain Cancer CentersOTHER | 1 | Feb 12, 2014 | clinicaltrials |
| NCT00922129 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | withdrawn | Phase 2 / Phase 3 | 0 | St. Joseph's Healthcare HamiltonOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00681148 | Botulinum Toxin Injection With Prostate Brachytherapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 1 | Nov 21, 2013 | clinicaltrials |
| NCT01617174 | Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Nov 8, 2013 | clinicaltrials |
| NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Milton S. Hershey Medical CenterOTHER | 0 | Sep 27, 2013 | clinicaltrials |
| NCT01197209 | Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer | withdrawn | Phase 1 | 0 | Momotaro-Gene Inc.INDUSTRY | 1 | Aug 23, 2013 | clinicaltrials |
| NCT00685633 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | withdrawn | Phase 2 | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Aug 20, 2013 | clinicaltrials |
| NCT00796874 | Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Jul 25, 2013 | clinicaltrials |
| NCT01899391 | Periperal Blood Lymphocytes During Prostate RT | withdrawn | — | 0 | University Health Network, TorontoOTHER | 0 | Jul 15, 2013 | clinicaltrials |
| NCT00003517 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00084565 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | withdrawn | Phase 2 | 0 | Fox Chase Cancer CenterOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT01733836 | Prostate Cancer Active Surveillance Metformin Trial | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00043212 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | withdrawn | Phase 3 | 0 | Northwest BiotherapeuticsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00577980 | Testosterone in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 29, 2013 | clinicaltrials |
| NCT00691977 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | withdrawn | Phase 1 | 0 | Virginia Commonwealth UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00258466 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | withdrawn | Phase 3 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 8, 2013 | clinicaltrials |
| NCT01478308 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | New Mexico Cancer Research AllianceOTHER | 0 | Mar 6, 2013 | clinicaltrials |
| NCT00559481 | Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | withdrawn | N/A | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 1, 2013 | clinicaltrials |
| NCT01663415 | A Study to Evaluate the Safety and Efficacy of Enzalutamide in Chemotherapy-Naïve, Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | Astellas Pharma Global Development, Inc.INDUSTRY | 0 | Sep 17, 2012 | clinicaltrials |
| NCT00811031 | Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 30, 2012 | clinicaltrials |
| NCT00877617 | Quality of Life in Men With High Risk Localized Prostate Cancer | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00242931 | Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jun 1, 2012 | clinicaltrials |
| NCT00244920 | Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | May 28, 2012 | clinicaltrials |
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | withdrawn | Phase 1 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT01132599 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | Cancer Research UKOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00736164 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | withdrawn | Phase 2 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Feb 6, 2012 | clinicaltrials |
| NCT01153113 | Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Dec 2, 2011 | clinicaltrials |
| NCT00728533 | Open-Label, Randomised Parallel-Group Study | withdrawn | Phase 3 | 0 | Ferring PharmaceuticalsINDUSTRY | 0 | Mar 18, 2011 | clinicaltrials |
| NCT00255268 | CMAB vs IMAB in Metastatic Prostate Cancer | withdrawn | Phase 4 | 15 | AstraZenecaINDUSTRY | 1 | Aug 28, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Oct 23, 2014source: clinicaltrials